The IDH1 and IDH2 mutations were subsequently indentified in the majority of lower grade gliomas, mostly in diffuse astrocytomas (62%), anaplastic astrocytomas (46%), oligodendrogliomas (77%), and anaplastic oligodendrogliomas (73%) [37]. This evidence concerns the gene IDH1 and oligodendroglioma.